HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julhash U Kazi Selected Research

gedatolisib

10/2019Corrigendum to "The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)" [Cancer Lett. 392 (1) (2017) 9-16].
1/2017The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julhash U Kazi Research Topics

Disease

16Neoplasms (Cancer)
01/2022 - 07/2008
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2019 - 10/2012
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2019 - 01/2017
4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2019 - 01/2017
4Breast Neoplasms (Breast Cancer)
03/2016 - 01/2013
3Leukemia
02/2021 - 06/2013
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2013 - 10/2013
1Neuroblastoma
11/2018
1Weight Loss (Weight Reduction)
01/2017
1Melanoma (Melanoma, Malignant)
01/2017
1Hypoxia (Hypoxemia)
03/2016
1Hematologic Neoplasms (Hematological Malignancy)
02/2014
1Colonic Neoplasms (Colon Cancer)
07/2008
1Carcinogenesis
12/2007

Drug/Important Bio-Agent (IBA)

8Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019 - 01/2012
7Phosphotransferases (Kinase)IBA
01/2018 - 02/2014
5Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2013
4Pharmaceutical PreparationsIBA
01/2021 - 12/2013
3Protein Kinase CIBA
12/2013 - 12/2007
2CateninsIBA
01/2022 - 02/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
02/2021 - 01/2019
2GlucocorticoidsIBA
02/2021 - 01/2019
2gedatolisibIBA
10/2019 - 01/2017
2Sorafenib (BAY 43-9006)FDA Link
07/2019 - 01/2019
2AZD3463IBA
07/2019 - 01/2019
2tyrosine receptor (receptor, tyrosine)IBA
01/2018 - 07/2015
2Messenger RNA (mRNA)IBA
01/2018 - 01/2012
2Transcription Factors (Transcription Factor)IBA
01/2017 - 03/2016
2EnzymesIBA
07/2008 - 12/2007
1Prednisolone (Predate)FDA LinkGeneric
02/2021
1Aurora KinasesIBA
02/2021
1Drug CombinationsIBA
01/2021
1ibrutinibIBA
11/2018
1CrizotinibIBA
11/2018
1Agammaglobulinaemia Tyrosine KinaseIBA
11/2018
1Anaplastic Lymphoma KinaseIBA
11/2018
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018
1dinaciclibIBA
10/2017
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017
1Tyrosine (L-Tyrosine)FDA Link
01/2017
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2016
1Estrogen ReceptorsIBA
03/2016
1Estrogen Receptor Modulators (Antiestrogen)IBA
03/2016
1CarcinogensIBA
12/2015
1LipidsIBA
11/2015
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
11/2015
1Cytokine Receptors (Cytokine Receptor)IBA
07/2015
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2015
1Cell Surface ReceptorsIBA
07/2015
1Biomarkers (Surrogate Marker)IBA
12/2014
1Keratin-19 (Keratin 19)IBA
12/2014
1fms-Like Tyrosine Kinase 3IBA
02/2014
1Syk KinaseIBA
02/2014
1Oncogene Proteins (Oncogene Protein)IBA
02/2014
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
06/2013
1Basic Helix-Loop-Helix Transcription FactorsIBA
01/2013
1Growth Factor ReceptorsIBA
10/2012
1Meclofenamic Acid (Meclofenamate)FDA LinkGeneric
07/2008
1sulindac sulfone (exisulind)IBA
07/2008
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
07/2008
1Indomethacin (Indometacin)FDA LinkGeneric
07/2008
1Celecoxib (Celebrex)FDA Link
07/2008
1Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
07/2008
1GuanosineIBA
07/2008
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2008

Therapy/Procedure

5Therapeutics
01/2021 - 02/2014